PSMA-617 manufacturers
- PSMA-617
-
- $0.00 / 10mg
-
2024-04-02
- CAS:1702967-37-0
- Min. Order: 10mg
- Purity: >95.00%
- Supply Ability: 10mg
- PSMA-617
-
- $0.00 / 1GRAM
-
2023-11-27
- CAS:1702967-37-0
- Min. Order: 1GRAM
- Purity: 99%
- Supply Ability: 20 TONS
|
| | PSMA-617 Basic information |
| Product Name: | PSMA-617 | | Synonyms: | PSMA-617;Vipivotide tetraxetan;L-Lysine, N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]-N6-[3-(2-naphthalenyl)-N-[[trans-4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]amino]methyl]cyclohexyl]carbonyl]-L-alanyl]-;Vipivotide tetraxetan (PSMA-617);PSMA617,Vipivotide tetraxetan;Actinium-225-PSMA-Trillium(BAY3563254) | | CAS: | 1702967-37-0 | | MF: | C49H71N9O16 | | MW: | 1042.14 | | EINECS: | | | Product Categories: | | | Mol File: | 1702967-37-0.mol |  |
| | PSMA-617 Chemical Properties |
| Boiling point | 1371.9±65.0 °C(Predicted) | | density | 1.322±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Water:150.0(Max Conc. mg/mL);100.13(Max Conc. mM)
DMSO:125.0(Max Conc. mg/mL);83.43(Max Conc. mM) | | form | Solid | | pka | 1.83±0.10(Predicted) | | color | White to off-white |
| | PSMA-617 Usage And Synthesis |
| Uses | PSMA-617 has been used in prostate cancer research, and is a promising prostate-specific membrane antigen-targeted theranostic agent. |
| | PSMA-617 Preparation Products And Raw materials |
|